The symptom burden index: Development and initial findings from use with patients with systemic sclerosis

Journal of Rheumatology

Volumn 37, Issue 8, 2010, Pages 1692-1698

  Kallen, Michael A ^a   Mayes, Maureen D ^b   Kriseman, Yana L ^c   De Achaval, Sofia B ^a   Cox, Vanessa L ^a   Suarez Almazor, Maria E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Pain measurement; Patient care management; Self assessment; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; BREATHING; CALCINOSIS; CHRONIC DISEASE; DYSPNEA; EATING; FEMALE; HAND; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; INTESTINE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36; SKIN; SYMPTOM BURDEN INDEX; SYSTEMIC SCLEROSIS;

ACTIVITIES OF DAILY LIVING; ATTITUDE TO HEALTH; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SELF-EXAMINATION; SEVERITY OF ILLNESS INDEX;

EID: 77955487127     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090504     Document Type: Article

References (14)

1. Valentini G. The assessment of the patient with systemic sclerosis. Autoimmun Rev 2003;2:370-6.
2. Hudson M, Steele R, Canadian Scleroderma Research Group, Baron M. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 2007;37:93-8.
3. Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, et al. Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol 2007;34:501-9. (Pubitemid 46364004)
4. Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, et al. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 2008;67:703-9. (Pubitemid 351571937)
5. Khanna D. A standardized core set for systemic sclerosis clinical trials. First step in development of combined response index. Rheumatology 2008;47 Suppl 5:v31-2.
6. Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003;30:1630-47. (Pubitemid 36835470)
7. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27-31.
8. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 1995;8:189-93.
9. Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, et al. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2005;24:48-54. (Pubitemid 40214800)
10. Furst DE. Update on clinical trials in the rheumatic diseases. Curr Opin Rheumatol 1998;10:123-8.
11. Furst DE, Khanna D, Mattucci-Cerinic M, Silman AJ, Merkel PA, Foeldvari I; OMERACT 7 Special Interest Group. Scleroderma - Developing measures of response. J Rheumatol 2005;32:2477-80.
12. Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-40. (Pubitemid 40676492)
13. Ruof J, Bruhlmann P, Michel BA, Stucki G. Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology 1999;38:535-42. (Pubitemid 29504839)
14. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M. Disease and symptom burden in systemic sclerosis: A patient perspective. J Rheumatol 2007;34:1718-26. (Pubitemid 47267616)